• Develop and implement strategic plans for the company, including the development of the drug portfolio, market access, business combination, and funding strategies

• Oversee all research and development efforts, including conducting a Phase 3 clinical trial in metastatic breast cancer and the development of a portfolio of new oncology treatments in various cancer indications

• Lead fundraising efforts to secure the necessary capital to support the company’s growth plans via equity and non-dilutive sources of capital

• Lead the company to a successful IPO on a major stock exchange (NASDAQ and/or EURONEXT) to raise capital and provide liquidity to the shareholders

• Build and lead a world-class organization to implement the strategy

• Lead the effort to establish strategic partnerships with Pharma/Biotech companies that may be interested in the company’s oncology assets

• Build strong relationships with investors, analysts, the scientific community, and key opinion leaders in oncology

• Shape the culture and values of the company, setting high standards for performance, accountability, and ethics

Bachelor’s degree required, Master’s Degree/MBA preferred

• a strong scientific/medical background and a deep knowledge of the oncology therapeutics landscape
• at least 15 years of experience in the biopharmaceutical industry with prior international experience (EU/US)
• a successful track record in the valorization of late stage clinical assets in oncology at a global level (Phase III clinical development, regulatory processes, market access strategies)
• successful involvements in IPOs and fund raising operations
• expertise in IP protection
• experience in establishing successful strategic partnerships with pharmaceutical/biotech companies
• demonstrated ability to build, lead and manage a late stage biotech organization
• excellent communication and interpersonal skills, with the ability to influence and lead both internal and external stakeholders
• English is a must, French is a plus.